These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Novel series of substituted biphenylmethyl urea derivatives as MCH-R1 antagonists for the treatment of obesity. Galiano S, Ceras J, Cirauqui N, Pérez S, Juanenea L, Rivera G, Aldana I, Monge A. Bioorg Med Chem; 2007 Jun 01; 15(11):3896-911. PubMed ID: 17407817 [Abstract] [Full Text] [Related]
31. Biphenyl amides and isosteres as MCH R1 antagonists. Hertzog DL, Witty DR. Curr Top Med Chem; 2007 Jun 01; 7(15):1455-70. PubMed ID: 17897032 [Abstract] [Full Text] [Related]
32. Design and synthesis of novel hydantoin-containing melanin-concentrating hormone receptor antagonists. Balavoine F, Malabre P, Alleaume T, Rey A, Cherfils V, Jeanneton O, Seigneurin-Venin S, Revah F. Bioorg Med Chem Lett; 2007 Jul 01; 17(13):3754-9. PubMed ID: 17448659 [Abstract] [Full Text] [Related]
33. 2,4-Diaminopyridine delta-opioid receptor agonists and their associated hERG pharmacology. Owen DR, Rodriguez-Lens M, Corless MD, Gaulier SM, Horne VA, Kinloch RA, Maw GN, Pearce DW, Rees H, Ringer TJ, Ryckmans T, Stammen BL. Bioorg Med Chem Lett; 2009 Mar 15; 19(6):1702-6. PubMed ID: 19231185 [Abstract] [Full Text] [Related]
34. Synthesis and SAR of thieno[3,2-b]pyridinyl urea derivatives as urotensin-II receptor antagonists. Lim CJ, Oh SA, Lee BH, Oh KS, Yi KY. Bioorg Med Chem Lett; 2014 Dec 15; 24(24):5832-5835. PubMed ID: 25452001 [Abstract] [Full Text] [Related]
35. Identification of a new small molecule chemotype of Melanin Concentrating Hormone Receptor-1 antagonists using pharmacophore-based virtual screening. Helal MA, Chittiboyina AG, Avery MA. Bioorg Med Chem Lett; 2019 Dec 15; 29(24):126741. PubMed ID: 31678007 [Abstract] [Full Text] [Related]
37. Discovery of 4-(dimethylamino)quinazolines as potent and selective antagonists for the melanin-concentrating hormone receptor 1. Kanuma K, Omodera K, Nishiguchi M, Funakoshi T, Chaki S, Semple G, Tran TA, Kramer B, Hsu D, Casper M, Thomsen B, Beeley N, Sekiguchi Y. Bioorg Med Chem Lett; 2005 May 16; 15(10):2565-9. PubMed ID: 15863317 [Abstract] [Full Text] [Related]
38. Aminomethyl tetrahydronaphthalene biphenyl carboxamide MCH-R1 antagonists--Increasing selectivity over hERG. Meyers KM, Kim N, Méndez-Andino JL, Hu XE, Mumin RN, Klopfenstein SR, Wos JA, Mitchell MC, Paris JL, Ackley DC, Holbert JK, Mittelstadt SW, Reizes O. Bioorg Med Chem Lett; 2007 Feb 01; 17(3):814-8. PubMed ID: 17107791 [Abstract] [Full Text] [Related]
39. Design, synthesis and evaluation of MCH receptor 1 antagonists--Part III: Discovery of pre-clinical development candidate BI 186908. Oost T, Heckel A, Kley JT, Lehmann T, Müller S, Roth GJ, Rudolf K, Arndt K, Budzinski R, Lenter M, Lotz RR, Maier GM, Markert M, Thomas L, Stenkamp D. Bioorg Med Chem Lett; 2015 Aug 15; 25(16):3275-80. PubMed ID: 26105194 [Abstract] [Full Text] [Related]
40. Discovery of novel diarylketoxime derivatives as selective and orally active melanin-concentrating hormone 1 receptor antagonists. Suzuki T, Kameda M, Ando M, Miyazoe H, Sekino E, Ito S, Masutani K, Kamijo K, Takezawa A, Moriya M, Ito M, Ito J, Nakase K, Matsushita H, Ishihara A, Takenaga N, Tokita S, Kanatani A, Sato N, Fukami T. Bioorg Med Chem Lett; 2009 Sep 15; 19(18):5339-45. PubMed ID: 19683441 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]